Napp Pharmaceuticals Ltd - Strategic SWOT Analysis Review

September 2018 | 21 pages | ID: NA249994CE9EN
GlobalData

Abstracts

Napp Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Napp Pharmaceuticals Ltd (Napp Pharmaceuticals), a subsidiary of Napp Pharmaceutical Holdings Ltd, is a commercial pharmaceutical company. It develops and manufactures pharmaceutical products with a focus on the UK market. The company offers prescription only medicines for respiratory diseases, such as asthma; inflammatory conditions, such as ulcerative colitis, ankylosing spondylitis, Crohn’s disease, rheumatoid arthritis and psoriasis; pain management; blood cancers; and cardiovascular conditions. Napp Pharmaceuticals is part of Napp Pharmaceutical Group of companies, which includes Bard Pharmaceuticals Limited, a production and supply chain company that manufactures and exports medicines to more than 40 countries worldwide. Napp Pharmaceuticals is headquartered in Cambridge, the UK.

Napp Pharmaceuticals Ltd Key Recent Developments

Apr 06,2018: Statement from Napp on the treatment of chronic pain with opioid analgesics
Mar 12,2018: Napp Shortlisted for HSJ’s “Best Pharmaceutical Partnership with the NHS” Award

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Napp Pharmaceuticals Ltd - Key Facts
Napp Pharmaceuticals Ltd - Key Employees
Napp Pharmaceuticals Ltd - Major Products and Services
Napp Pharmaceuticals Ltd - History
Napp Pharmaceuticals Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Napp Pharmaceuticals Ltd - Business Description
Napp Pharmaceuticals Ltd - Corporate Strategy
Napp Pharmaceuticals Ltd - SWOT Analysis
SWOT Analysis - Overview
Napp Pharmaceuticals Ltd - Strengths
Napp Pharmaceuticals Ltd - Weaknesses
Napp Pharmaceuticals Ltd - Opportunities
Napp Pharmaceuticals Ltd - Threats
Napp Pharmaceuticals Ltd - Key Competitors

SECTION 3 – COMPANY’S RECENT DEVELOPMENTS

Apr 06, 2018: Statement from Napp on the treatment of chronic pain with opioid analgesics
Mar 12, 2018: Napp Shortlisted for HSJ’s “Best Pharmaceutical Partnership with the NHS” Award

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Napp Pharmaceuticals Ltd, Key Facts
Napp Pharmaceuticals Ltd, Key Employees
Napp Pharmaceuticals Ltd, Major Products and Services
Napp Pharmaceuticals Ltd, History
Napp Pharmaceuticals Ltd, Subsidiaries
Napp Pharmaceuticals Ltd, Joint Venture
Napp Pharmaceuticals Ltd, Key Competitors

COMPANIES MENTIONED

Teva Pharmaceuticals Ltd
Pulmagen Therapeutics LLP
Psynova Neurotech Ltd
Pfizer Consumer Healthcare Ltd
GW Pharmaceuticals Plc
GlaxoSmithKline Plc
G.R. Lane Health Products Ltd
AstraZeneca Plc